Ildong Pharmaceutical

Peak

Phase 4 asset with established safety/efficacy profile driving post-marketing surveillance and formulation optimization.

Twotopsplus

Share Interview Share Compensation

Help build intelligence for Ildong Pharmaceutical

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Pipeline & Clinical Trials

A Post-marketing Surveillance to Assess Safety and Efficacy of Twotopsplus.

N/A

Clinical Trials (1)

NCT03655288A Post-marketing Surveillance to Assess Safety and Efficacy of Twotopsplus.

N/A

Post Marketing Surveillance of Telostop TAB (Telmisartan/Rosuvastatin) for Evaluating the Safety and

Idiopathic Pulmonary Fibrosis

N/A

Clinical Trials (1)

NCT03742544Post Marketing Surveillance of Telostop TAB (Telmisartan/Rosuvastatin) for Evaluating the Safety and Efficacy

N/A

N/A

Clinical Trials (1)

NCT03761082Post Marketing Surveillance of PIRESPA® TAB 200mg (Pirfenidone) for Evaluating the Safety and Efficacy

N/A

RHT-3201

Dermatitis, Atopic

N/A

Clinical Trials (1)

NCT03907228Study to Evaluate the Use of RHT-3201 in SCORAD Reduction in Young Patients With Atopic Dermatitis

N/A

hENT1

Pancreatic Cancer

N/A

Clinical Trials (1)

NCT02486497Adjuvant Gemcitabine Versus 5-FU/Leucovorin Based on hENT1 Immunostaining

N/A

Mixed Dyslipidemia

N/A

Clinical Trials (1)

NCT03648788A Post-marketing Surveillance to Assess Safety and Efficacy of Rosuvatatin/Ezetimibe

N/A

A Post-marketing Surveillance to Assess Safety and Efficacy of Besivo

Chronic Hepatitis b

N/A

Clinical Trials (1)

NCT03642340A Post-marketing Surveillance to Assess Safety and Efficacy of Besivo

N/A

Belviq Tablet® Post Marketing Surveillance Protocol

Weight Loss

N/A

Clinical Trials (1)

NCT03741010Belviq Tablet® Post Marketing Surveillance Protocol

N/A

gQ-lab daily

Irritable Bowel Syndrome (IBS)

N/A

Clinical Trials (1)

NCT03964103qQ-lab Daily-IBS for Irritable Bowel Syndrome

N/A

A Post-marketing Surveillance to Assess Safety and Efficacy of Telostop Plus Tab.

Hypertension, Dyslipidemia

N/A

Clinical Trials (1)

NCT03648801A Post-marketing Surveillance to Assess Safety and Efficacy of Telostop Plus Tab.

N/A

ID110521156

Healthy Adult Subjects

Phase 1

Clinical Trials (1)

NCT06063291Single Ascending Oral Dose Phase 1 Study of ID110521156 in Healthy Adult Subjects

Phase 1

Clopidogrel

Acute Coronary Syndrome

Phase 1

Clinical Trials (1)

NCT02034292Safety Study of APD-791 With Aspirin and/or Clopidogrel

Phase 1

Telmisartan 80mg

Phase 1

Clinical Trials (1)

NCT03889145A Study to Evaluate the Drug-drug Interaction Between Telmisartan, Amlodipine and Hydrochlorothiazide

Phase 1

ID1803

Phase 1

Clinical Trials (1)

NCT04185090To Evaluate the Pharmacokinetic/Pharmacodynamic Interactions and Safety Between ID1801 and ID1803 in Healthy Male Adults

Phase 1

Belviq 10mg

Phase 1

Clinical Trials (1)

NCT01880502Pharmacokinetic Study of Belviq in Adult Korean Volunteers

Phase 1

APD791

Acute Coronary Syndrome

Phase 1

Clinical Trials (1)

NCT02419820Dose-escalation, Repeated and Single Oral Dosing Study

Phase 1

Nateglinide

Healthy Volunteers

Phase 1

Clinical Trials (1)

NCT02088918A Open-label, Single-dose, 2-Sequence, 2-Period, Crossover Study to Assess Safety and Pharmacokinetics of a Nateglinide/Metformin HCl Combined Tablet Compared With a Nateglinide 120 mg Tablet and Metformin HCl 500 mg Tablet Under Fasting Conditions in Healthy Male Subjects

Phase 1

Cilnidipine/Valsartan

Phase 1

Clinical Trials (1)

NCT02343250A Bioequivalence Study Comparing Cilnidipine/Valsartan Combination With Coadministration of Cilnidipine and Valsartan

Phase 1

Treatment A

Phase 1

Clinical Trials (1)

NCT02300688Bioequivalence Study to Compare the Pharmacokinetics of Besifovir in Healthy Adult Volunteers

Phase 1

[Part 1.1] IDG-16177

Type 2 Diabetes

Phase 1

Clinical Trials (1)

NCT04982705IDG-16177 for the Evaluation of Its Safety and Pharmacokinetics

Phase 1

ID140009

Dyslipidemias

Phase 1

Clinical Trials (1)

NCT05259020To Evaluate the Pharmacokinetics and the Safety of ID14009 Compared to Coadministration of ID1805 With ID1803 in Healthy Adult Volunteers

Phase 1

ID119031166M

Healthy Participants

Phase 1

Rebamipide

Phase 1

Clinical Trials (1)

NCT02106130A Drug Interaction Study of Mosapride and Rebamipide

Phase 1

IDP-73152 mesylate 40 mg

Phase 1

Clinical Trials (1)

NCT01904318A Phase I Study of IDP-73152 Mesylate in Health Male Volunteer

Phase 1

COL-144 50mg

Phase 1

Clinical Trials (1)

NCT03937648Study to Evaluate Pharmacokinetics, Safety, and Tolerability Ildong COL-144 Tablet in Korean Healthy Volunteers

Phase 1

TAH Tablet

Phase 1

Clinical Trials (1)

NCT02739672Clinical Trial to Compare the Pharmacokinetics of TAH Tablet in Comparison to the Co-administration of Telmisartan, Amlodipine and Hydrochlorothiazide in Healthy Male Volunteers

Phase 1

NOV140101

Advanced Solid Tumors

Phase 1

Immediate release capsule

Phase 1

Clinical Trials (1)

NCT02103647Clinical Trial to Compare The Pharmacokinetics of A Pregabalin Controlled Release Tablet 300mg and Immediate Release Formulation

Phase 1

C - V - C+V

Phase 1

Clinical Trials (1)

NCT01838967A Drug Interaction Study of Cilnidipine and Valsartan

Phase 1

ID120040002

Phase 1

Clinical Trials (1)

NCT05663879Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of ID120040002 in Healthy Volunteers

Phase 1

ID110521156

Healthy Adult Subjects

Phase 1

Clinical Trials (1)

NCT06635226Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ID110521156 in Healthy Adult Subjects

Phase 1

Besifovir Dipivoxil Maleate

Renal Impairment

Phase 1

Clinical Trials (1)

NCT04249908Pharmacokinetics of Besifovir in Adults With Normal and Impaired Renal Function

Phase 1

TAH Tablet

Phase 1

Clinical Trials (1)

NCT03032315Compare the Pharmacokinetics of TAH(80/10/12.5) Tablet in Comparison to the Co-administration of Telmisartan, Amlodipine and Hydrochlorothiazide in Healthy Male Volunteers

Phase 1

cinidipine, valsartan

Healthy Volunteers

Phase 1

Clinical Trials (1)

NCT02088008A Bioequivalence Study Comparing Cilnidipine/Valsartan Combination Tablet With Coadministration of Cilnidipine and Valsartan

Phase 1

Lyrica

Hypertension With Hyperlipidemia

Phase 1

Clinical Trials (1)

NCT02103686Study for Comparing The Pharmacokinetics of A Pregabalin Controlled Release Tablet 300mg With Immediate Release Formulation and to Assess the Effect of High Fat Diet in Healthy Male Subjects

Phase 1

ID1201

Alzheimer Disease

Phase 2

Clinical Trials (1)

NCT03363269Evaluate the Efficacy and Safety of ID1201 for Dose-finding in Mild Alzheimer's Disease

Phase 2

Rabeprazole 20mg bid

Esophageal Disease

Phase 3

Clinical Trials (1)

NCT04001400Treatment Response of High-dose and Standard-dose Rabeprazole for Extra-esophageal Reflux.

Phase 3

Telmisartan/Amlodipine

Phase 3

Clinical Trials (1)

NCT03566316Efficacy/Safety of Telmisartan/Amlodipine/Rosuvastatin in Hypertensive Patients With Hyperlipidemia

Phase 3

Telmisartan 80mg

Benign Prostate Hyperplasia

Phase 3

Clinical Trials (1)

NCT02087540Efficacy and Safety of Telmisartan/Rosuvastatin Co-administration in Hypertensive Patients With Hyperlipidemia

Phase 3

Tamsulosin

Phase 3

Clinical Trials (1)

NCT02827578Efficacy and Safety of Tamsulosin/Solifenacin Combination Therapy in Patients With Voiding Symptoms and Moderate to Severe Storage Symptoms Due to Benign Prostate Hyperplasia

Phase 3

Rosuvastatin/Ezetimibe

Hypercholesterolemia

Phase 3

Clinical Trials (1)

NCT02251847The Efficacy and Safety of a Combination Therapy of Rosuvastatin and Ezetimibe Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients

Phase 3

Rosuvastatin

Mixed Dyslipidemias

Phase 3

Clinical Trials (1)

NCT02262143Phase III Study of Rosuvastatin and Fenofibrate Versus Rosuvastatin in Mixed Dyslipidemia

Phase 3

Motireb 5/100 mg

Functional Dyspepsia

Phase 3

Clinical Trials (1)

NCT02831543Clinical Trial to Assess the Efficacy and Safety of Combination Therapy of Motireb 5/100 mg in Functional Dyspepsia Patients.

Phase 3

Rosuvastatin

Hypercholesterolemia

Phase 3

Clinical Trials (1)

NCT02749994A Clinical Trial to Compare the Efficacy and Safety of a Combination Therapy of Ezetimibe and Rosuvastatin Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients (I-ROSETTE Study)

Phase 3

Lasmiditan 50mg

Acute Migraine

Phase 3

Clinical Trials (1)

NCT04218162Lasmiditan Compared to Placebo in the Acute Treatment of Migraine in Korean

Phase 3

Besifovir 150mg

Phase 3

Clinical Trials (1)

NCT02792088Study to Assess the Antiviral Activity and Safety Endpoints for the Treatment of Besifovir 150mg Compared to Tenofovir 300mg in Chronic Hepatitis B Patients Who Have Resistance to Nucleoside Analogues

Phase 3

Telmisartan/Amlodipine+Hydrochlorothiazide

Essential Hypertension

Phase 3

Clinical Trials (1)

NCT02738632Efficacy and Safety of TAH Combination in Comparison With Telmisartan/Amlodipine Combination for Essential Hypertension Patients

Phase 3

valsartan 160mg, cilnidipine 10mg, cilinidipine 5mg

Phase 3

Clinical Trials (1)

NCT02145104Efficacy/Safety of Cilnidipine Plus Valsartan Versus Valsartan in Patients With Hypertension

Phase 3

besifovir 150mg